Evidence map›Paper›PMID 33589718›Full record

ArticleCommunications biology2021

Identification of efficient prokaryotic cell-penetrating peptides with applications in bacterial biotechnology.

Hyang-Mi Lee, Jun Ren, Kha Mong Tran, Byeong-Min Jeon, Won-Ung Park, Hyunjoo Kim, Kyung Eun Lee, Yuna Oh, Myungback Choi, Dae-Sung Kim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. TargetingInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hyang-Mi LeeDepartment of Biomedical Engineering, Chung-Ang University, Seoul, Republic of Korea.ORCID 0000-0003-0662-3359
Jun RenDepartment of Biomedical Engineering, Chung-Ang University, Seoul, Republic of Korea.
Kha Mong TranDepartment of Biomedical Engineering, Chung-Ang University, Seoul, Republic of Korea.
Byeong-Min JeonDepartment of Biotechnology, Korea University, Seoul, Republic of Korea.
Won-Ung ParkDepartment of Biotechnology, Korea University, Seoul, Republic of Korea.
Hyunjoo KimDepartment of Biomedical Engineering, Chung-Ang University, Seoul, Republic of Korea.
Kyung Eun LeeAdvanced Analysis Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.
Yuna OhAdvanced Analysis Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.
Myungback ChoiDepartment of Biomedical Engineering, Chung-Ang University, Seoul, Republic of Korea.
Dae-Sung KimDepartment of Biotechnology, Korea University, Seoul, Republic of Korea.
Dokyun NaDepartment of Biomedical Engineering, Chung-Ang University, Seoul, Republic of Korea. blisszen@cau.ac.kr.
Chung-Ang University · KRKorea University · KRKorea Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In bacterial biotechnology, instead of producing functional proteins from plasmids, it is often necessary to deliver functional proteins directly into live cells for genetic manipulation or physiological modification. We constructed a library of cell-penetrating peptides (CPPs) capable of delivering protein cargo into bacteria and developed an efficient delivery method for CPP-conjugated proteins. We screened the library for highly efficient CPPs with no significant cytotoxicity in Escherichia coli and developed a model for predicting the penetration efficiency of a query peptide, enabling the design of new and efficient CPPs. As a proof-of-concept, we used the CPPs for plasmid curing in E. coli and marker gene excision in Methylomonas sp. DH-1. In summary, we demonstrated the utility of CPPs in bacterial engineering. The use of CPPs would facilitate bacterial biotechnology such as genetic engineering, synthetic biology, metabolic engineering, and physiology studies.

Indexed as

BiotechnologyIndustrial MicrobiologyAnimalsCell-Penetrating PeptidesCHO CellsCricetulusElectroporationEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialGenetic EngineeringHEK293 CellsHumansMethylomonasPeptide LibraryPlasmidsCell-Penetrating PeptidesEscherichia coli ProteinsPeptide Library

Identifiers

PMID33589718
PMCPMC7884711
OpenAlexW3129313953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.